{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:35:10Z","timestamp":1790778910692,"version":"4.1.0"},"reference-count":31,"publisher":"CAIRN","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,11]]},"abstract":"<jats:p>Les antir\u00e9troviraux provoquent une panoplie d\u2019effets secondaires qui sont non n\u00e9gligeables puisqu\u2019ils nuisent \u00e0 la qualit\u00e9 de vie des personnes vivant avec le VIH (PVVIH). Une prise en charge efficace des effets secondaires est n\u00e9cessaire pour maintenir la qualit\u00e9 de vie et l\u2019adh\u00e9sion au traitement. La relation patient-m\u00e9decin joue un r\u00f4le important dans la prise en charge des effets secondaires et elle influence l\u2019exp\u00e9rience des effets secondaires chez les PVVIH. Cette th\u00e9orisation ancr\u00e9e explore la relation patient-m\u00e9decin dans le contexte des effets secondaires. Cinquante PVVIH de la r\u00e9gion d\u2019Ottawa\/Gatineau ont particip\u00e9 \u00e0 une entrevue semi-structur\u00e9e afin de partager leur exp\u00e9rience avec les effets secondaires. Quatre cat\u00e9gories ont \u00e9merg\u00e9 de l\u2019analyse\u00a0: mod\u00e8le de soins, pouvoir m\u00e9dical (cat\u00e9gorie centrale), strat\u00e9gies et impacts. Les r\u00e9sultats montrent que les m\u00e9decins exercent un monopole dans la prise en charge des PVVIH, ces derni\u00e8res mettent alors en place plusieurs modes de r\u00e9sistance pour contrer l\u2019autorit\u00e9 m\u00e9dicale. Elles doivent \u00e9galement d\u00e9velopper leurs propres strat\u00e9gies pour att\u00e9nuer leurs effets secondaires. Malgr\u00e9 tout, une relation patient-m\u00e9decin conflictuelle engendre diff\u00e9rents impacts qui peuvent \u00eatre d\u00e9vastateurs pour les PVVIH (isolement, abandon et souffrance).<\/jats:p>","DOI":"10.3917\/rsi.132.0020","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:27:16Z","timestamp":1524097636000},"page":"20-37","source":"Crossref","is-referenced-by-count":3,"title":["La relation patient-m\u00e9decin\u00a0: une th\u00e9orisation ancr\u00e9e de l\u2019exp\u00e9rience des effets secondaires des antir\u00e9troviraux"],"prefix":"10.3917","volume":"N\u00b0 132","author":[{"given":"Caroline","family":"Dufour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilou","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2273","reference":[{"key":"rb1","doi-asserted-by":"crossref","unstructured":"1Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med. 2012 Apr\u00a0;2(4)\u00a0:a007161.","DOI":"10.1101\/cshperspect.a007161"},{"key":"rb2","doi-asserted-by":"crossref","unstructured":"2Est\u00e9 JA, Cihlar T. Current status and challenges of antiretroviral research and therapy. Antiviral Res. 2010 Jan\u00a0;85(1)\u00a0:25-33.","DOI":"10.1016\/j.antiviral.2009.10.007"},{"key":"rb3","doi-asserted-by":"crossref","unstructured":"3Al-Dakkak I, Patel S, McCann E, Gadkari A, Prajapati G, Maiese EM, et al. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy\u00a0: a systematic review and meta-analysis. AIDS care. 2013 Apr\u00a0;25(4)\u00a0:400-14.","DOI":"10.1080\/09540121.2012.712667"},{"key":"rb4","doi-asserted-by":"crossref","unstructured":"4Margolis AM, Heverling H, Pham PA, Stolbach A. A review of the toxicity of HIV medications. J Med Tox. 2014 Mar\u00a0;10(1)\u00a0:26-39.","DOI":"10.1007\/s13181-013-0325-8"},{"key":"rb5","doi-asserted-by":"crossref","unstructured":"5Hawkins T. Understanding and managing the adverse effects of antiretroviral therapy. Antiviral Res. 2010 Jan\u00a0;85(1)\u00a0:201-9.","DOI":"10.1016\/j.antiviral.2009.10.016"},{"key":"rb6","doi-asserted-by":"crossref","unstructured":"6Park-Wyllie LY, Strike CS, Antoniou T, Bayoumi A M. Adverse quality of life consequences of antiretroviral medications. AIDS care. 2007 Feb\u00a0;19(2)\u00a0:252-7.","DOI":"10.1080\/09540120600774180"},{"key":"rb7","doi-asserted-by":"crossref","unstructured":"7Wilson HS, Hutchinson SA, Holzemer WL. Reconciling incompatibilities\u00a0: a grounded theory of HIV medication adherence and symptom management. Qual Health Res. 2002 Dec\u00a0;12(10)\u00a0: 1309-22.","DOI":"10.1177\/1049732302238745"},{"key":"rb8","doi-asserted-by":"crossref","unstructured":"8Anema A, Weiser SD, Fernandes KA, Ding E, Brandson EK, Palmer A, et al. High prevalence of food insecurity among HIV-infected individuals receiving HAART in a resource-rich setting. AIDS Care. 2011 Feb\u00a0;23(2)\u00a0:221-30.","DOI":"10.1080\/09540121.2010.498908"},{"key":"rb9","doi-asserted-by":"crossref","unstructured":"9Dekoven M, Makin C, Slaff S, Marcus M, Maiese EM. Economic burden of HIV antiretroviral therapy adverse events in the United States. J Int Assoc Provid AIDS Care. 2016 Jan-Feb\u00a0;15(1)\u00a0:66-76.","DOI":"10.1177\/2325957415594883"},{"key":"rb10","doi-asserted-by":"crossref","unstructured":"10Gagnon M, Holmes D. Bodies in mutation\u00a0: understanding lipodystrophy among women living with HIV\/AIDS. Res theory Nurs Pract. 2011\u00a0;25(1)\u00a0:23-38.","DOI":"10.1891\/1541-6577.25.1.23"},{"key":"rb11","doi-asserted-by":"crossref","unstructured":"11Gagnon M, Holmes D. Women living with HIV\/AIDS and the bodily transformation process known as the lipodystrophy syndrome\u00a0: a grounded theory study. J Res Nurs. 2012 May\u00a0;17(3)\u00a0:215-28.","DOI":"10.1177\/1744987110389407"},{"key":"rb12","doi-asserted-by":"crossref","unstructured":"12Gagnon M, Holmes D. \u201cSo far it\u2019s been choosing which side effects I want or I can deal with\u201d\u00a0: a grounded theory of HIV treatment side effects among people living with HIV. Aporia. 2016 Jan\u00a0;8(1)\u00a0:19-40.","DOI":"10.18471\/rbe.v30i3.16348"},{"key":"rb13","doi-asserted-by":"crossref","unstructured":"13Gagnon M. Understanding the experience of reconstructive treatments from the perspective of people who suffer from facial lipoatrophy\u00a0: a qualitative study. Int J Nurs Stud. 2012 May\u00a0; 49(5)\u00a0:539-48.","DOI":"10.1016\/j.ijnurstu.2011.11.001"},{"key":"rb14","doi-asserted-by":"crossref","unstructured":"14Prosperi MC, Fabbiani M, Fanti I, Zaccarelli M, Colafigli M, Mondi A, et al. Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients\u00a0: a retrospective cohort study. BMC Inf Dis. 2012 Apr\u00a0;12(1)\u00a0:296.","DOI":"10.1186\/1471-2334-12-296"},{"key":"rb15","doi-asserted-by":"crossref","unstructured":"15Vervoort SC, Borleffs JC, Hoepelman AI, Grypdonck MH. Adherence in antiretroviral therapy\u00a0: a review of qualitative studies. Aids. 2007 Jan\u00a0; 21(3)\u00a0:271-81.","DOI":"10.1097\/QAD.0b013e328011cb20"},{"key":"rb16","unstructured":"16International Association of Physicians in Aids Care-IAPAC. Global HIV\/AIDS survey reveals critical gap in patient-physician conversations that may affect long-term health outcomes [En ligne]. CISION\u00a0; 2010. [cit\u00e9 le 9 juillet 2016]. Disponible\u00a0: http:\/\/www.prnewswire.com\/news-releases\/global-hivaids-survey-reveals-critical-gap-in-patient-physician-conversations-that-may-affect-long-term-health-outcomes-98820224.html"},{"key":"rb17","doi-asserted-by":"crossref","unstructured":"17Brashers E, Haas M, Klingle S, Neidig L. Collective AIDS activism and individuals\u2019 perceived self advocacy in physician patient communication. Hum Communi Res. 2000 Jul\u00a0; 26(3)\u00a0:372-402.","DOI":"10.1111\/j.1468-2958.2000.tb00762.x"},{"key":"rb18","unstructured":"18Guiget M. VIH au f\u00e9minin\u00a0: l\u2019enqu\u00eate \u00c8ve [En ligne]. France\u00a0: S\u00e9ronet\u00a0; 2015. [cit\u00e9 le 9 juillet 2016]. Disponible\u00a0: http:\/\/www.seronet.info\/article\/femmes-et-vih-les-premiers-resultats-de-lenquete-eve-70804"},{"key":"rb19","doi-asserted-by":"crossref","unstructured":"19Persson A, Race K, Wakeford E. HIV health in context\u00a0: negotiating medical technology and lived experience. Health. 2003 Oct\u00a0;7(4)\u00a0:397-415.","DOI":"10.1177\/13634593030074002"},{"key":"rb20","doi-asserted-by":"crossref","unstructured":"20Wong WT, Ussher JM. Life with HIV and AIDS in the era of effective treatments\u00a0:\u2018It\u2019s not just about living longer\u00a0!\u2019. Soc Theory Health. 2008 May\u00a0;6(2)\u00a0:117-31.","DOI":"10.1057\/sth.2008.4"},{"key":"rb21","unstructured":"21Charmaz K. Constructing grounded theory. 2e \u00e9d. Sage\u00a0; 2014."},{"key":"rb22","unstructured":"22Charmaz K. Grounded theory in the 21st century\u00a0: applications for advancing social justice studies. Dans\u00a0: The SAGE handbook of qualitative research. 3e \u00e9d. Sage\u00a0; 2005. p.507-35."},{"key":"rb23","doi-asserted-by":"crossref","unstructured":"23Paill\u00e9 P. L\u2019analyse par th\u00e9orisation ancr\u00e9e. Cahiers de recherche sociologique. 1994\u00a0;(23)\u00a0:147-81.","DOI":"10.7202\/1002253ar"},{"key":"rb24","doi-asserted-by":"crossref","unstructured":"24Brion J. The patient\u2013provider relationship as experienced by a diverse sample of highly adherent HIV-infected people. J Assoc Nurses AIDS Care. 2014 Apr 30\u00a0;25(2)\u00a0:123-34.","DOI":"10.1016\/j.jana.2013.01.006"},{"key":"rb25","doi-asserted-by":"crossref","unstructured":"25Mutchler MG, Wagner G, Cowgill BO, McKay T, Risley B, Bogart LM, et al. Improving HIV\/AIDS care through treatment advocacy\u00a0: going beyond client education to empowerment by facilitating client-provider relationships. AIDS Care. 2011 Jan\u00a0;23(1)\u00a0:79-90.","DOI":"10.1080\/09540121.2010.496847"},{"key":"rb26","doi-asserted-by":"crossref","unstructured":"26Apollo A, Golub SA, Wainberg ML, Indyk D. Patient-provider relationships, HIV, and adherence\u00a0: requisites for a partnership. Soc Work in Health Care. 2006 Jun 19\u00a0;42(3-4)\u00a0:209-24.","DOI":"10.1300\/J010v42n03_13"},{"key":"rb27","doi-asserted-by":"crossref","unstructured":"27Brashers E, Haas M, Klingle S, Neidig L. Collective AIDS activism and individuals\u2019 perceived self advocacy in physician patient communication. Hum Commun Res. 2000 Jul\u00a0;1\u00a0;26(3)\u00a0:372-402.","DOI":"10.1111\/j.1468-2958.2000.tb00762.x"},{"key":"rb28","doi-asserted-by":"crossref","unstructured":"28McGee K, Relf M, Harmon J. The development of an HIV trainingprogram for nurse practitioners. J Assoc Nurses AIDS Care. 2016 May\u00a0;27(3)\u00a0:240-45.","DOI":"10.1016\/j.jana.2015.11.008"},{"key":"rb29","doi-asserted-by":"crossref","unstructured":"29Bradley-Springer L, Stevens L, Webb A. Every nurse is an HIV nurse. Am J Nurs. 2010 Mar\u00a0;110(3)\u00a0:32-41.","DOI":"10.1097\/01.NAJ.0000368950.95881.b1"},{"key":"rb30","doi-asserted-by":"crossref","unstructured":"30Wilson I, Landon B, Hirschhorn L, McInnes K, Ding L, Cleary P, et al. Quality of HIV care provided by nurse practitioners, physician assistants, and physicians. Ann Intern Med. 2005 Nov\u00a0;143(10)\u00a0:729-36.","DOI":"10.7326\/0003-4819-143-10-200511150-00010"},{"key":"rb31","unstructured":"31Yen-Chin C, Yi-Yin L, Hsiao-Ying L, Yun-Hui P, Wen-Chien K, Nai-Ying K.The impact of nurse-led case management on the quality of HIV care. J Nurs. 2014 Jun\u00a0;61(3)\u00a0:69-78."}],"container-title":["Recherche en soins infirmiers"],"original-title":[],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T12:52:49Z","timestamp":1702039969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cairn.info\/revue-recherche-en-soins-infirmiers-2018-1-page-20.htm?ref=doi"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4,11]]}},"URL":"https:\/\/doi.org\/10.3917\/rsi.132.0020","relation":{},"ISSN":["0297-2964"],"issn-type":[{"value":"0297-2964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,11]]}}}